171 related articles for article (PubMed ID: 36194345)
1. Comparison of plasma metanephrines in patients with cyanotic and acyanotic congenital heart disease.
Jensterle M; Podbregar A; Janež A; Rakusa M; Goricar K; Prokšelj K
Endocrine; 2022 Dec; 78(3):580-586. PubMed ID: 36194345
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
[TBL] [Abstract][Full Text] [Related]
3. Congenital Cyanotic Heart Disease and the Association with Pheochromocytomas and Paragangliomas.
Jones RB; Cohen DL
Curr Cardiol Rep; 2023 Nov; 25(11):1451-1460. PubMed ID: 37847359
[TBL] [Abstract][Full Text] [Related]
4. Deconjugated urinary metanephrine, normetanephrine and 3-methoxytyramine in laboratory diagnosis of pheochromocytoma and paraganglioma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Bešťák J; Widimský J
Physiol Res; 2015; 64(Suppl 2):S313-22. PubMed ID: 26680494
[TBL] [Abstract][Full Text] [Related]
5. Genetic Analysis of Pheochromocytoma and Paraganglioma Complicating Cyanotic Congenital Heart Disease.
Ogasawara T; Fujii Y; Kakiuchi N; Shiozawa Y; Sakamoto R; Ogawa Y; Ootani K; Ito E; Tanaka T; Watanabe K; Yoshida Y; Kimura N; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S
J Clin Endocrinol Metab; 2022 Aug; 107(9):2545-2555. PubMed ID: 35730597
[TBL] [Abstract][Full Text] [Related]
6. Correlation between the size of pheochromocytoma and the level of metanephrines.
Rezkallah E; Elsaify A; Hanna R; Elsaify W
Endocr Regul; 2023 Jan; 57(1):183-190. PubMed ID: 37715982
[No Abstract] [Full Text] [Related]
7. Co-Occurrence of Pheochromocytoma-Paraganglioma and Cyanotic Congenital Heart Disease: A Case Report and Literature Review.
Zhao B; Zhou Y; Zhao Y; Zhao Y; Wu X; Bi Y; Luo Y; Ji Z; Rong S
Front Endocrinol (Lausanne); 2018; 9():165. PubMed ID: 29719528
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma.
Bílek R; Zelinka T; Vlček P; Dušková J; Michalský D; Novák K; Václavíková E; Widimský J
Physiol Res; 2017 Sep; 66(Suppl 3):S397-S408. PubMed ID: 28948824
[TBL] [Abstract][Full Text] [Related]
9. Plasma free metanephrine, normetanephrine, and 3-methoxytyramine for the diagnosis of pheochromocytoma/paraganglioma.
Gupta P; Khurana ML; Khadgawat R; Bal CS; Kumar G; Sharma SC; Tandon N
Indian J Endocrinol Metab; 2015; 19(5):633-8. PubMed ID: 26425473
[TBL] [Abstract][Full Text] [Related]
10. A Case of Paraganglioma with Cyanotic Congenital Heart Disease.
Wahab NA; Chien BH; Omar MR; Aziz AA; Mustafa N; Sukor N; Kamaruddin NA
Acta Med Indones; 2021 Jan; 53(1):77-81. PubMed ID: 33818409
[TBL] [Abstract][Full Text] [Related]
11. Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma.
Eisenhofer G; Deutschbein T; Constantinescu G; Langton K; Pamporaki C; Calsina B; Monteagudo M; Peitzsch M; Fliedner S; Timmers HJLM; Bechmann N; Fankhauser M; Nölting S; Beuschlein F; Stell A; Fassnacht M; Prejbisz A; Lenders JWM; Robledo M
Clin Chem Lab Med; 2020 Oct; 59(2):353-363. PubMed ID: 33001846
[TBL] [Abstract][Full Text] [Related]
12. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
Procopiou M; Finney H; Akker SA; Chew SL; Drake WM; Burrin J; Grossman AB
Eur J Endocrinol; 2009 Jul; 161(1):131-40. PubMed ID: 19383804
[TBL] [Abstract][Full Text] [Related]
14. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma.
Eisenhofer G; Lattke P; Herberg M; Siegert G; Qin N; Därr R; Hoyer J; Villringer A; Prejbisz A; Januszewicz A; Remaley A; Martucci V; Pacak K; Ross HA; Sweep FC; Lenders JW
Ann Clin Biochem; 2013 Jan; 50(Pt 1):62-9. PubMed ID: 23065528
[TBL] [Abstract][Full Text] [Related]
15. Low number of neurosecretory vesicles in neuroblastoma impairs massive catecholamine release and prevents hypertension.
Mühlethaler-Mottet A; Uccella S; Marchiori D; La Rosa S; Daraspe J; Balmas Bourloud K; Beck Popovic M; Eugster PJ; Grouzmann E; Abid K
Front Endocrinol (Lausanne); 2022; 13():1027856. PubMed ID: 36531507
[TBL] [Abstract][Full Text] [Related]
16. Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.
Araujo-Castro M; Nattero Chavez L; Martínez Lorca A; Molina-Cerrillo J; Alonso-Gordoa T; Pascual-Corrales E
Clin Exp Med; 2022 Aug; 22(3):359-370. PubMed ID: 34591219
[TBL] [Abstract][Full Text] [Related]
17. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
Christensen TT; Frystyk J; Poulsen PL
Scand J Clin Lab Invest; 2011 Dec; 71(8):695-700. PubMed ID: 22023043
[TBL] [Abstract][Full Text] [Related]
18. Performance of plasma free metanephrines in diagnosis of pheochromocytomas and paragangliomas in the population of Asturias.
Martínez-Morillo E; Valdés Gallego N; Eguia Ángeles E; Fernández Fernández JC; Prieto García B; Álvarez FV
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):312-319. PubMed ID: 30391255
[TBL] [Abstract][Full Text] [Related]
19. Plasma-free vs deconjugated metanephrines for diagnosis of phaeochromocytoma.
Pamporaki C; Därr R; Bursztyn M; Glöckner S; Bornstein SR; Lenders JW; Pacak K; Krinner A; Eisenhofer G
Clin Endocrinol (Oxf); 2013 Oct; 79(4):476-83. PubMed ID: 23461656
[TBL] [Abstract][Full Text] [Related]
20. Multifocal pheochromocytoma-paraganglioma in a 29-year-old woman with cyanotic congenital heart disease.
Wcislak SM; King WS; Waller BR; Goins N; Dickson PV
Surgery; 2019 Jan; 165(1):228-231. PubMed ID: 30340856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
